^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SGN-CD30C

i
Other names: SGN-CD30C
News
Trials
Company:
Pfizer
Drug class:
Topoisomerase I inhibitor, CD30-targeted antibody-drug conjugate
Related drugs:
News
Trials